soliris drug - Yahoo Search Results

Ads
related to: soliris drug
FDA-Approved Treatment Options - See Treatment Efficacy Info

www.relapsed-multiple-myeloma.com
Explore FDA-Approved Dosing And Treatment Options At The Official Physician Website. Review Important Safety Information And Treatment Efficacy Data. Learn More Today.
About Multiple Myeloma
Learn More About Treatments At

First Relapse For Your Patients.

Efficacy Information
Review Clinical Data, Results,

Study Overviews, And More.

Access & Reimbursement
Find Support, Tools, And Resources

For HCPs, Caregivers And Patients.

Safety Information
View Safety Profiles For

A Combination Treatment.

HCP FAQs
Discover Answers To Commonly Asked

Questions At The Official HCP Site.

Connect With A Rep
Contact A Field Representative For

Questions Or To Schedule A Visit.
Try A Proven Treatment Option - Moderate To Severe Psoriasis

www.treat-plaque-psoriasis.com
Learn About A Treatment Option For Plaque Psoriasis. Visit The Patient Website Today. Discover How A Moderate To Severe Plaque Psoriasis Treatment May Help To Get Clear Skin.
Register For Savings
PsO & Psoriatic Arthritis
Clinical Trial Results
Plaque Psoriasis In Kids

Search results

- Could This Biosimilar Drug Candidate Be a Winner for Amgen?
  Motley Fool· 2 years ago
  The pharmaceutical industry is fraught with risk and also filled with opportunity. On one hand, the...
- AstraZeneca gets FDA OK for rare disease drug acquired in Alexion buyout
  BioPharma Dive via Yahoo Finance· 3 weeks ago
  The approval of Voydeya as an add-on therapy for an uncommon blood disease validates a bet Alexion...
- Amgen (AMGN) Posts Positive Data from Soliris' Biosimilar Study
  Zacks via Yahoo Finance· 2 years ago
  Amgen's (AMGN) phase III study evaluating ABP 959, a biosimilar candidate to Soliris for treating...
- AstraZeneca Makes A Break For A Buy Point On Massive Third-Quarter Growth
  Investor's Business Daily· 1 year ago
  AstraZeneca leaned on cancer and diabetes drugs in the third-quarter, leading to double-digit sales...
- AstraZeneca's Blood Clot Treatment Hits Primary Goal In Rare Blood Disorder Trial
  Benzinga via Yahoo Finance· 2 years ago
  AstraZeneca Plc (NASDAQ: AZN) said its Danicopan add-on anti-blood-clotting drug met a primary...
- Is This Monster Stock on the Verge of a Home Run?
  Motley Fool· 2 years ago
  Late last month, AstraZeneca's (NASDAQ: AZN) rare disease drug called Ultomiris received the green light from the European Commission to treat adult...
- Novartis (NVS) Gets FDA Nod for Rare Blood Disorder Drug
  Zacks via Yahoo Finance· 4 months ago
  Novartis NVS announced that the FDA approved iptacopan as the first oral monotherapy for the...
- Novartis gets FDA approval of closely watched rare disease drug
  BioPharma Dive via Yahoo Finance· 4 months ago
  Dive Brief: The Food and Drug Administration has approved a new Novartis drug for adults with a rare...
- Here's What is Driving Amgen (AMGN) Stock's Outperformance
  Zacks via Yahoo Finance· 1 year ago
  Amgen AMGN is one of the biggest biotech companies in the world, with a strong presence in the...
- Roche autoimmune disease drug disappoints in closely watched trial
  BioPharma Dive via Yahoo Finance· 1 month ago
  Though the medicine hit its goal in a Phase 3 study in myasthenia gravis, the results fell short of...